Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AdaptHealth (AHCO) EBIT Margin (2019 - 2025)

AdaptHealth has reported EBIT Margin over the past 7 years, most recently at 8.66% for Q4 2025.

  • Quarterly results put EBIT Margin at 8.66% for Q4 2025, down 2006.0% from a year ago — trailing twelve months through Dec 2025 was 2.8% (down 529.0% YoY), and the annual figure for FY2025 was 2.8%, down 529.0%.
  • EBIT Margin for Q4 2025 was 8.66% at AdaptHealth, down from 7.53% in the prior quarter.
  • Over the last five years, EBIT Margin for AHCO hit a ceiling of 11.59% in Q3 2021 and a floor of 57.34% in Q3 2023.
  • Median EBIT Margin over the past 5 years was 6.92% (2023), compared with a mean of 1.63%.
  • Biggest five-year swings in EBIT Margin: crashed -6434bps in 2023 and later soared 6522bps in 2024.
  • AdaptHealth's EBIT Margin stood at 9.84% in 2021, then crashed by -65bps to 3.43% in 2022, then crashed by -841bps to 25.38% in 2023, then skyrocketed by 145bps to 11.4% in 2024, then tumbled by -176bps to 8.66% in 2025.
  • The last three reported values for EBIT Margin were 8.66% (Q4 2025), 7.53% (Q3 2025), and 9.9% (Q2 2025) per Business Quant data.